Dan is CEO of Pelagos Pharma and a Co-Founder and Venture Partner at Mercury Fund ($600M AUM). He is also Director and Co-Founder at OmniScience, a company providing AI solutions to life sciences companies for research and clinical trials. Dan was Director and founding CEO of Courier Therapeutics (acquired, pre-clinic, for over $500M in cash and milestone payments). Dan has been an investor and director of numerous companies in life sciences and AI/ML differentiated businesses including companies include Resonant Therapeutics, Swift Biosciences (acquired by Danaher), Benson Hill (NYSE: BHIL), Confluence Life Sciences (acquired by ACRS), Dnatrix, Avenu Medical (acquired by Medtronic), and Asky Therapeutics (stealth).